ArticleOrthopedic reviews2025
Direct Anterior Approach and Posterior Approach for Total Hip Arthroplasty: A Systematic Umbrella Review of Meta-Analyses of Randomized Controlled Trials.
Article in Orthopedic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Total Hip Arthroplasty (THA) has revolutionized orthopaedic surgery, with demand expected to double by 2030. This umbrella review assessed the efficacy and patient satisfaction of the direct anterior approach (DAA) versus the posterior approach (PA). Methods: We searched three databases. Quality was assessed using A Measurement Tool to Assess Systematic Reviews 2 (AMSTAR-2), and discrepancies were investigated through matrices (PROSPERO: CRD42023450069). Results: Of 11 SRs/MAs comparing DAA to PA, two were low and nine critically low quality. PA reduced operation duration (OD) in five out of eight direct meta-analyses (DMAs) (mean difference [MD] 13.74 to 18.92). PA showed less blood loss (BL) in one DMA (MD 91.87 [27.99, 155.74]), while DAA showed less BL in another (MD -67.02 [-131.46, -2.58]). DAA decreased length of stay (LOS) in three DMAs (MD -0.31 to -0.56). DAA also showed less pain on post-operative days (POD) 1 and 2 in two DMAs (MD -0.65 [-0.91, -0.38] and MD -0.67 [-1.34, -0.01]). No significant differences were observed at post-operative weeks (POW) 2, POW6, or post-operative months (POM) 12. DAA significantly improved hip function at POW2 in one DMA and POW6 in two DMAs and one network meta-analysis (NMA) (MD 3.7 to 6.80), but no significant differences were found at POM6 or POM12.Discrepancies in OD, BL, and LOS results stemmed from study selection factors including non-randomization, language barriers, approach comparisons, search periods, and inconsistencies in reporting. Conclusion: DAA offers advantages in early pain reduction and functional improvement due to its muscle-sparing technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.